Sunday Special: Cannabis as a first resort palliative treatment for cancer symptoms is being strongly validated in a series of recent studies.

In this (yes, Israeli) research (…Israel is getting so far ahead of federally hobbled research in the US that it’s not even funny. Thanks, DEA….) …but we digress, so again, in this research … almost 96% of the nearly 3,000 patients reported at least some to major improvement in their symptomatology, irrespective of the course of their cancers.

And for you deeper students, note that we’re sharing the whole scientific paper today. They’re most often behind expensive “paywalls” so we have more often have to rely on media stories about most of them. Highly instrucitional reading…!

Also, by the way, we hope you’re noticing that many of the studies we’re sharing recently are involving larger and larger numbers of patients than a few years ago – and studies done over months and more – which is more than the studies accepted as validating many drugs.

Studies by serious research scientists. It’s simply the FDA’s by now beyond absurd insistence that whole plant cannabis isn’t a medicine, so they don’t recognize these studies (though there are signs of cracks appearing in this policy – but only cracks) – which is the only reason people can still argue there isn’t enough proof to end federal prohibition and to at least re-schedule cannabis.

This is why UT’s flimsy HB195 hospice trial bill is clearly an inadequate measure and why it can do no better than delay these KNOWN benefits to cancer patients:

Cannabis is a safe and effective palliative treatment for cancer in a way nothing else is when both positive benefits AND absence of adverse side effects are taken into effect. Plus it’s most often replacing dangerous, addictive opioids, so another net social and medical benefit.

It’s really time to end the madness … and end it now … don’t you think….??

#MMJ #Research #Cancer #Palliative #Israel #UTpol #UahNext #TRUCE    

See full article – Prospective analysis of safety and efficacy of medical cannabis in large unselected population of patients with cancer